- Home
- BNR vs CLPR Comparison
BNR vs CLPR Comparison
Compare BNR & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- CLPR
- Stock Information
- Founded
- BNR 2014
- CLPR 2015
- Country
- BNR China
- CLPR United States
- Employees
- BNR N/A
- CLPR N/A
- Industry
- BNR Medical Specialities
- CLPR Real Estate Investment Trusts
- Sector
- BNR Health Care
- CLPR Real Estate
- Exchange
- BNR Nasdaq
- CLPR Nasdaq
- Market Cap
- BNR 69.6M
- CLPR 77.0M
- IPO Year
- BNR 2020
- CLPR 2017
- Fundamental
- Price
- BNR $6.66
- CLPR $4.08
- Analyst Decision
- BNR
- CLPR Sell
- Analyst Count
- BNR 0
- CLPR 2
- Target Price
- BNR N/A
- CLPR N/A
- AVG Volume (30 Days)
- BNR 5.1K
- CLPR 98.8K
- Earning Date
- BNR 03-27-2025
- CLPR 03-13-2025
- Dividend Yield
- BNR N/A
- CLPR 9.59%
- EPS Growth
- BNR N/A
- CLPR N/A
- EPS
- BNR N/A
- CLPR N/A
- Revenue
- BNR $72,832,704.00
- CLPR $145,595,000.00
- Revenue This Year
- BNR $52.90
- CLPR N/A
- Revenue Next Year
- BNR $48.35
- CLPR N/A
- P/E Ratio
- BNR N/A
- CLPR N/A
- Revenue Growth
- BNR N/A
- CLPR 6.78
- 52 Week Low
- BNR $2.62
- CLPR $3.38
- 52 Week High
- BNR $8.99
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- BNR 50.28
- CLPR 43.74
- Support Level
- BNR $5.58
- CLPR $3.92
- Resistance Level
- BNR $6.85
- CLPR $4.18
- Average True Range (ATR)
- BNR 0.28
- CLPR 0.24
- MACD
- BNR -0.06
- CLPR 0.05
- Stochastic Oscillator
- BNR 62.01
- CLPR 43.75
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.